exhibitors

The following companies are exhibiting at the ChinaBio Investor Forum - Beijing. Exhibiting opportunities are still available - please contact us for more information.

ChinaBio® Consulting

ChinaBio® Consulting is focused exclusively on the life science industry in China. We work with established and emerging biotechnology, medical device and diagnostics companies with operations in China, or seeking to do business in China. ChinaBio assists China life science companies with their business strategy, funding and U.S. connections, and we help U.S. companies with their China strategy, competitor and technology analysis and China connections. We also perform primary research and have developed databases of technologies, companies, and physicians in China.

www.ChinaBioLLC.com  

Zhongguancun Life Science Park

Zhongguancun (ZGC) Life Science Park is a professional science park developed by the Beijing Municipal Government. It is an important part of ZGC Science and Technology Park system, and is developed according to the Written Approval from the State Council to accelerate the development of the ZGC Science and Technology Park, to launch the Beijing "248" Technology Innovation Project, and to develop the knowledge-based economy in the capital area.

www.lifesciencepark.com.cn  

Beijing Pharma and Center (BPBC)

Beijing Pharma and Biotech Center (BPBC) is the principal health research agency of the Beijing Local Government; it is a component of Beijing Municipal Commission for Science and Technology (BMCST). Established in 1996 and initially function as the development and implementation of Beijing Government Grants Policy, BPBC serves as the focal point for advisory industrial policy, mandatory project management for government and international bridge between Chinese Biotech & Pharmaceutical Industry and the rest of the world. BPBC is composed of five divisions: Project Management, Strategy Study, Business Liaison and International Affairs, General Administration and Financial Management Divisions.

www.newlife.org.cn/en  

Merck & Co., Inc. USA

Merck is a global research-driven pharmaceutical company dedicated to putting patients first. We discover, develop, manufacture, and market vaccines and medicines to address unmet medical needs, directly and through alliances with our partners. Our mission is to provide people with superior products and services by developing innovations and solutions that improve the quality of life. The focus of research at Merck is on innovation in all areas of drug research and development, working on programs to satisfy unmet medical needs. With approximately 60,000 employees, Merck conducts research at 9 major research centers worldwide, manufactures products in 28 facilities, and operates in more than 140 countries.

www.merck.com/licensing  

Perkins Coie LLP

Perkins Coie is a leading international law firm offering a full spectrum of legal services. With nearly 700 lawyers in 15 offices across the United States and in China, the firm serves great companies ranging in size from start-ups to FORTUNE 100. Many of the firm's clients are leaders in traditional industries and emerging technology markets.

www.perkinscoie.com

Unitalen Attorneys at Law

Unitalen is the largest law firm in China focused exclusively on intellectual property (IP) - patents, trademarks and copyrights - with 26 offices throughout China, including Beijing and Shanghai, and over 500 attorneys. Unitalen's Life Science Practice, headquartered in Beijing, can help emerging China biotechs and U.S. companies secure the IP necessary for success. Their professional staff includes many PhDs educated in China and the U.S.

www.unitalenlaw.com  

The Balloch Group

The Balloch Group ("TBG") was established in 2001 by Howard Balloch (Canada's ambassador to China from 1996 to 2001). TBG has since grown from a market-entry consultancy working with North American clients in China to a leading advisory and merchant banking firm serving both domestic Chinese companies and multinational corporations. TBG was ranked one of the top five largest M&A and private placement advisors by China Venture in 2007.

www.ballochgroup.com

Chiral Quest, Inc.

Chiral Quest (CQ) is a technology and product company, creating chiral solutions for the pharmaceutical industry, assisting major pharma, generic, biotech companies to develop processes for manufacture of their drugs. Chiral Quest (CQ) owned 13 international patents and built a significant technology platform. The company’s technology platform and products address customer needs through the integration of proprietary chiral catalysts, novel building block processes, API’s and manufacturing capability. Chiral Quest will take advantages of its current technology platform to compete in strategic pharma intermediates and the generic API’s worldwide market.

www.chiralquest.com  

Shangdong Baofa Cancer Therapeutics, Inc.

Shandong Baofa Cancer Therapeutics (SBCT), Inc, was founded in 2002, focusing on clinical development of new anti-cancer regimens by optimizing formulation and delivery for existing drugs. The major shareholders include Shandong Yinzuo Department Store Co., Ltd and Shenzhen Tiancheng Investment Co. The company has two cancer hospitals, Taimei and Jinan Baofa cancer hospitals, one medical device company with the marketed product Ozone, and one R&D center. One of its pharmaceutical products, TriCancerVac, is expected to complete preclinical testing soon for filing IND in China.

www.bfyl.cn  

Sanlugen PharmaTech

Sanlugen PharmaTech is a new professional CRO company found in 2007 and operated in San Diego and Jinan, China. Sanlugen provides high quality and cost-effective Chemistry and drug discovery R&D services for global clients. All founders have been trained in US and each member had more than fifteen years working and management experiences in US academy and Biotech/Pharmaceutical industry; have co-authored >100 publications, co-inventors on over 50 patent application and received 18 granted in US.

www.sanlugen.com  

Beijing ShengYiYao Technology & Development

Beijing ShengYiYao Technology & Development Co., Ltd. was registered in Zhong-Guan-Cun Desheng Science & Technology Garden of Beijing in April, 2001 with registration capital of 3.85 million Yuan. KMG is the innovative product of the company, possessing independent intellectual property rights and invention patent. As a domestic product, KMG is the exclusive one on market for intravascular remobilization authorized by Chinese National Food and Drugs Surveillance Administrative Bureau. The company will engage in the innovation and development of high polymer biological products and materials related with interventional treatment in the future. Comments from physicians and hospitals are highly appreciated, which would benefit both the patients and our corporation undoubtedly.

www.kmg.net.cn